摘要
急性血管反应试验对指导肺动脉高压患者的治疗是重要的,它可以选择出适合长期钙通道阻滞剂治疗的患者,判断患者预后。目前用于急性血管反应试验的药物主要有前列环素、腺苷、一氧化氮。肺动脉高压患者进行急性血管反应试验可能产生严重不良反应,应在持续监测的情况下由有经验的人员完成。
Acute vasoreactivity testing can be important to guide treatment of patients with pulmonary hypertension in that it helps to select patients who can benefit from long-term use of calcium channel blockers and to predict the treatment outcomes.Drugs currently used in acute vasoreactivity test mainly include prostacycline,adenosine and nitric oxide.Acute vasoreactivity testing can cause severe adverse effects in patients with pulmonary hypertension,and therefore must be undertaken by experienced practitioners under continuous monitoring.
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2010年第12期1083-1084,共2页
Chinese Journal of Practical Internal Medicine
关键词
肺动脉高压
急性血管反应试验
钙通道阻滞剂
pulmonary hypertension
acute vasoreactivity test
calcium channel blocker
